Arbutus to Participate in Two Upcoming Investor Conferences

Arbutus Biopharma

WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company, announced that the Arbutus management team will participate in and host one-on-one meetings at the following two upcoming investor conferences:

  • H.C. Wainwright 25th Annual Global Investment Conference: Formal Presentation on September 12, 2023 at 3:30 pm ET
  • Baird’s 2023 Global Healthcare Conference: Fireside Chat on September 13, 2023 at 7:55 am ET

To access the live webcast of the presentations please visit: https://investor.arbutusbio.com/events-presentations. An archived replay of the webcast will be available on the Arbutus website for a limited time after the event.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.

READ:  Arbutus Biopharma Co-Founder Dr. Michael Sofia to Retire After a Storied Career in Antiviral Drug Discovery